News

How cancer patients make treatment decisions


 

Doctor consults with a cancer

patient and her father

Photo by Rhoda Baer

A survey of more than 5000 cancer patients suggests there are a number of factors that might make a patient more likely to involve family members in treatment decisions.

A patient’s gender, age, marital status, native language, insurance status, and even past military service all appeared to impact family involvement in care decisions.

Gabriela Hobbs, MD, of Harvard Medical School in Boston, Massachusetts, and her colleagues conducted this research and reported the results in Cancer.

The researchers surveyed 5284 patients with a new diagnosis of lung or colon cancer, asking patients how they involved their families in treatment decisions.

Only 1.5% of patients reported complete family control over decisions. Nearly half of patients (49.4%) said they and family members shared decision-making responsibilities equally, 22.1% of patients reported some family input, and 28.5% reported little or no input from their families.

Asian and Hispanic patients who did not speak English were more likely than their peers to report equally shared decisions with their families. Likewise, patients who were married, female, older, and insured were more likely to share decision-making equally with their families.

Veterans were the least likely to share decision-making with their families, even when the researchers adjusted for marital status and social support.

“Understanding how patients vary in their inclusion of family members in decisions—by ethnicity, language spoken, marital status, sex, age, insurance status, and veteran status—may help physicians to better assess their patients’ preferences for engaging family members in decisions,” Dr Hobbs said.

“As we move to more patient-centered models of care, such assessments may help doctors personalize the care they offer their patients.”

Dr Hobbs noted that as therapies for cancer patients improve, they are also becoming increasingly complex, making it challenging for patients and providers to determine the optimal therapy for each patient. Therefore, knowing how patients make decisions and understanding the role families play in decision-making is crucial for optimizing patient participation in treatment decisions.

“Our study suggests that not all patients wish to include family in the same way,” Dr Hobbs said. “By raising awareness of these preferences, we hope that physicians will be aware of these variations and elicit their patient’s preference on how they wish to include, or not to include, families in decision-making.”

Recommended Reading

Recognition of latest CLL therapies highlights new options for other cancers
MDedge Hematology and Oncology
Evolutionary findings may aid cancer drug development
MDedge Hematology and Oncology
Ibrutinib demonstrates efficacy in CLL after allo-HSCT
MDedge Hematology and Oncology
Neural stem cells may fight chemo brain
MDedge Hematology and Oncology
CRT may pose long-term risk of hormone deficiencies
MDedge Hematology and Oncology
Cancer patients rarely make inappropriate requests, study shows
MDedge Hematology and Oncology
Leukemia, lymphoma cause more distress in young adults
MDedge Hematology and Oncology
Signs may predict death in cancer patients
MDedge Hematology and Oncology
Approved TKI could treat drug-resistant CML, ALL
MDedge Hematology and Oncology
Predicting outcomes of allo-HSCT in ALL
MDedge Hematology and Oncology